
Can Disproportionality Analysis of Post-marketing Case Reports be Used for Comparison of Drug Safety Profiles?
Michel, Christiane, Scosyrev, Emil, Petrin, Michael, Schmouder, RobertVolume:
37
Langue:
english
Journal:
Clinical Drug Investigation
DOI:
10.1007/s40261-017-0503-6
Date:
May, 2017
Fichier:
PDF, 650 KB
english, 2017